NCT06790030 is a clinical trial of CBT-T in Eating Disorders, sponsored by Altrecht.

Who is sponsoring NCT06790030?

NCT06790030 is sponsored by Altrecht.

What drugs are being tested in NCT06790030?

Interventions in NCT06790030: CBT-T.

What condition does NCT06790030 study?

NCT06790030 studies Eating Disorders.

Is NCT06790030 still recruiting?

NCT06790030 is currently recruiting now. Last updated 23 January 2025.

Last reviewed 2025-01-23 · How we verify

NCT06790030

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Does Self-Efficacy at the Start of Treatment Influence Treatment Outcome in Patients With EDs?

Recruiting now Last updated 23 January 2025

What this trial tests

trial testing CBT-T in Eating Disorders in 50 participants. Currently enrolling.

Timeline

28 March 2023

Primary endpoint
30 April 2025

1 December 2025

Quick facts

Lead sponsor	Altrecht
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	50
Start date	28 March 2023
Primary completion	30 April 2025
Estimated completion	1 December 2025
Sites	1 location across Netherlands

Drugs / interventions tested

CBT-T

Conditions studied

Eating Disorders — all drugs for Eating Disorders →

Sponsor

Altrecht

Who can join

18 and older, any sex, with Eating Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to contribute to the improvement of treatment for eating disorders, by identifying factors that might positively affect treatment outcome. The main questions it aims to answer are: 1. Do higher levels of self-efficacy positively predict a more positive treatment outcome? 2. Does self-efficacy in itself improve during treatment? 3. Do autonomous motivation, self-esteem and self-efficacy correlate? These factors will be measured in patients being treated for their eating disorders with Cognitive Behavior Therapy - Ten (CBT-T). Researchers will administer questionnaires at start, session four and end of treatment. Participants will: 1. Receive their treatment as usual. 2. fill in questionnaires at the start of treatment, session 4 and end of treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Eating Disorders

Currently open trials in the same condition.

NCT07237607 — Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders · NA · recruiting
NCT07295197 — Oral Indicators for ED Screening · recruiting
NCT07082777 — Recovery in Telling Life Stories · NA · recruiting
NCT07042672 — Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity · recruiting
NCT07017322 — Non-invasive Cranial Electrical Stimulation for Mealtime Anxiety in Adults With Eating Disorders · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06790030 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Altrecht
Last refreshed: 23 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06790030.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing